Membrane associated proteins, C21orf2 homolog Uncharacterized
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005929 | cilium | 4 | 10 |
| GO:0042995 | cell projection | 2 | 10 |
| GO:0043226 | organelle | 2 | 10 |
| GO:0043227 | membrane-bounded organelle | 3 | 10 |
| GO:0110165 | cellular anatomical entity | 1 | 10 |
| GO:0120025 | plasma membrane bounded cell projection | 3 | 10 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pescher et al. (upgregulation) | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A4ICR3
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.265 |
| CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.195 |
| CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.269 |
| CLV_PCSK_PC1ET2_1 | 138 | 140 | PF00082 | 0.269 |
| CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.519 |
| CLV_PCSK_SKI1_1 | 138 | 142 | PF00082 | 0.241 |
| CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.554 |
| CLV_PCSK_SKI1_1 | 214 | 218 | PF00082 | 0.335 |
| CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.216 |
| DEG_APCC_DBOX_1 | 213 | 221 | PF00400 | 0.471 |
| DEG_SCF_FBW7_1 | 179 | 184 | PF00400 | 0.536 |
| DOC_CDC14_PxL_1 | 87 | 95 | PF14671 | 0.402 |
| DOC_MAPK_gen_1 | 42 | 51 | PF00069 | 0.469 |
| DOC_MAPK_MEF2A_6 | 88 | 95 | PF00069 | 0.432 |
| DOC_PP1_RVXF_1 | 201 | 208 | PF00149 | 0.550 |
| DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.668 |
| DOC_USP7_UBL2_3 | 134 | 138 | PF12436 | 0.469 |
| DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.400 |
| DOC_USP7_UBL2_3 | 245 | 249 | PF12436 | 0.512 |
| DOC_WW_Pin1_4 | 157 | 162 | PF00397 | 0.623 |
| DOC_WW_Pin1_4 | 169 | 174 | PF00397 | 0.532 |
| DOC_WW_Pin1_4 | 177 | 182 | PF00397 | 0.725 |
| LIG_14-3-3_CanoR_1 | 139 | 145 | PF00244 | 0.505 |
| LIG_BRCT_BRCA1_1 | 203 | 207 | PF00533 | 0.439 |
| LIG_FHA_1 | 140 | 146 | PF00498 | 0.457 |
| LIG_FHA_1 | 190 | 196 | PF00498 | 0.702 |
| LIG_FHA_1 | 249 | 255 | PF00498 | 0.396 |
| LIG_FHA_1 | 90 | 96 | PF00498 | 0.412 |
| LIG_FHA_2 | 127 | 133 | PF00498 | 0.428 |
| LIG_FHA_2 | 192 | 198 | PF00498 | 0.532 |
| LIG_LIR_Gen_1 | 204 | 215 | PF02991 | 0.409 |
| LIG_LIR_Nem_3 | 204 | 210 | PF02991 | 0.428 |
| LIG_MYND_3 | 43 | 47 | PF01753 | 0.454 |
| LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.420 |
| LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.398 |
| LIG_SUMO_SIM_anti_2 | 219 | 226 | PF11976 | 0.428 |
| LIG_SUMO_SIM_anti_2 | 230 | 236 | PF11976 | 0.372 |
| LIG_SUMO_SIM_anti_2 | 35 | 41 | PF11976 | 0.402 |
| LIG_SUMO_SIM_anti_2 | 92 | 97 | PF11976 | 0.432 |
| LIG_SUMO_SIM_par_1 | 216 | 222 | PF11976 | 0.414 |
| LIG_TRAF2_1 | 194 | 197 | PF00917 | 0.530 |
| LIG_UBA3_1 | 67 | 75 | PF00899 | 0.513 |
| MOD_CDC14_SPxK_1 | 172 | 175 | PF00782 | 0.564 |
| MOD_CDK_SPK_2 | 157 | 162 | PF00069 | 0.575 |
| MOD_CDK_SPxK_1 | 169 | 175 | PF00069 | 0.565 |
| MOD_CDK_SPxxK_3 | 157 | 164 | PF00069 | 0.579 |
| MOD_CK1_1 | 189 | 195 | PF00069 | 0.586 |
| MOD_CK1_1 | 201 | 207 | PF00069 | 0.465 |
| MOD_CK1_1 | 219 | 225 | PF00069 | 0.428 |
| MOD_CK2_1 | 126 | 132 | PF00069 | 0.385 |
| MOD_CK2_1 | 191 | 197 | PF00069 | 0.666 |
| MOD_GlcNHglycan | 153 | 156 | PF01048 | 0.565 |
| MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.562 |
| MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.535 |
| MOD_GSK3_1 | 13 | 20 | PF00069 | 0.409 |
| MOD_GSK3_1 | 164 | 171 | PF00069 | 0.634 |
| MOD_GSK3_1 | 177 | 184 | PF00069 | 0.641 |
| MOD_GSK3_1 | 201 | 208 | PF00069 | 0.504 |
| MOD_N-GLC_1 | 198 | 203 | PF02516 | 0.474 |
| MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.269 |
| MOD_NEK2_1 | 13 | 18 | PF00069 | 0.326 |
| MOD_NEK2_1 | 149 | 154 | PF00069 | 0.454 |
| MOD_NEK2_1 | 206 | 211 | PF00069 | 0.478 |
| MOD_NEK2_1 | 216 | 221 | PF00069 | 0.435 |
| MOD_NMyristoyl | 1 | 7 | PF02799 | 0.323 |
| MOD_PKA_1 | 138 | 144 | PF00069 | 0.445 |
| MOD_PKA_1 | 164 | 170 | PF00069 | 0.663 |
| MOD_PKA_2 | 138 | 144 | PF00069 | 0.484 |
| MOD_Plk_1 | 225 | 231 | PF00069 | 0.371 |
| MOD_Plk_1 | 35 | 41 | PF00069 | 0.385 |
| MOD_Plk_1 | 54 | 60 | PF00069 | 0.385 |
| MOD_Plk_1 | 82 | 88 | PF00069 | 0.469 |
| MOD_Plk_4 | 216 | 222 | PF00069 | 0.358 |
| MOD_Plk_4 | 91 | 97 | PF00069 | 0.447 |
| MOD_ProDKin_1 | 157 | 163 | PF00069 | 0.624 |
| MOD_ProDKin_1 | 169 | 175 | PF00069 | 0.515 |
| MOD_ProDKin_1 | 177 | 183 | PF00069 | 0.725 |
| MOD_SUMO_rev_2 | 127 | 136 | PF00179 | 0.469 |
| TRG_DiLeu_BaEn_1 | 230 | 235 | PF01217 | 0.467 |
| TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.420 |
| TRG_Pf-PMV_PEXEL_1 | 143 | 147 | PF00026 | 0.197 |
| TRG_Pf-PMV_PEXEL_1 | 5 | 9 | PF00026 | 0.350 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P7V8 | Leptomonas seymouri | 65% | 100% |
| A0A0S4JS78 | Bodo saltans | 45% | 100% |
| A0A3S7XAD6 | Leishmania donovani | 100% | 100% |
| A4HNT1 | Leishmania braziliensis | 83% | 100% |
| D0A2P1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 94% |
| E9ASJ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
| O43822 | Homo sapiens | 31% | 100% |
| Q4Q205 | Leishmania major | 97% | 100% |
| Q8C6G1 | Mus musculus | 36% | 100% |
| Q9BV99 | Homo sapiens | 31% | 100% |
| V5DRP5 | Trypanosoma cruzi | 40% | 94% |